JP2019527041A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019527041A5 JP2019527041A5 JP2018565885A JP2018565885A JP2019527041A5 JP 2019527041 A5 JP2019527041 A5 JP 2019527041A5 JP 2018565885 A JP2018565885 A JP 2018565885A JP 2018565885 A JP2018565885 A JP 2018565885A JP 2019527041 A5 JP2019527041 A5 JP 2019527041A5
- Authority
- JP
- Japan
- Prior art keywords
- tcr
- seq
- acid sequence
- chain
- amino acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| LU93112 | 2016-06-17 | ||
| LU93112 | 2016-06-17 | ||
| EP17160260 | 2017-03-10 | ||
| EP17160260.0 | 2017-03-10 | ||
| PCT/EP2017/064729 WO2017216324A1 (en) | 2016-06-17 | 2017-06-16 | T cell receptors and uses thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019527041A JP2019527041A (ja) | 2019-09-26 |
| JP2019527041A5 true JP2019527041A5 (OSRAM) | 2020-07-09 |
| JP6989138B2 JP6989138B2 (ja) | 2022-01-05 |
Family
ID=59295160
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018565885A Expired - Fee Related JP6989138B2 (ja) | 2016-06-17 | 2017-06-16 | Ｔ細胞受容体及びその使用 |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US11732020B2 (OSRAM) |
| EP (1) | EP3472208B9 (OSRAM) |
| JP (1) | JP6989138B2 (OSRAM) |
| KR (1) | KR102436129B1 (OSRAM) |
| CN (1) | CN109715669B (OSRAM) |
| AU (1) | AU2017286310A1 (OSRAM) |
| CA (1) | CA3022129A1 (OSRAM) |
| ES (1) | ES2949342T3 (OSRAM) |
| WO (1) | WO2017216324A1 (OSRAM) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102016123847B3 (de) | 2016-12-08 | 2018-04-05 | Immatics Biotechnologies Gmbh | Neue T-Zellrezeptoren und deren Verwendung in Immuntherapie |
| MD3551221T2 (ro) | 2016-12-08 | 2022-04-30 | Immatics Biotechnologies Gmbh | Noi receptori de celule T și imunoterapie cu utilizarea acestora |
| EP3595708A4 (en) * | 2017-03-15 | 2020-12-16 | Fred Hutchinson Cancer Research Center | HIGH AFFINITY MAGE-A1 SPECIFIC TCRS AND THEIR USES |
| DE102017106305A1 (de) | 2017-03-23 | 2018-09-27 | Immatics Biotechnologies Gmbh | Neue T-Zellrezeptoren und deren Verwendung in Immuntherapien gegen prame-positive Krebsarten |
| US11236145B2 (en) | 2017-03-23 | 2022-02-01 | Immatics Biotechnologies Gmbh | T cell receptors and immune therapy using the same against PRAME positive cancers |
| LT3652215T (lt) | 2017-07-14 | 2021-05-25 | Immatics Biotechnologies Gmbh | Pagerinta dvejopo savitumo polipeptido molekulė |
| RU2694412C9 (ru) * | 2017-12-25 | 2019-09-18 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Российский национальный исследовательский медицинский университет им. Н.И. Пирогова" Министерства здравоохранения Российской Федерации (ФГБОУ ВО РНИМУ им. Н.И. Пирогова Минздрава России) | Моноклональные антитела и способы их применения |
| WO2019139972A1 (en) * | 2018-01-09 | 2019-07-18 | Board Of Regents, The University Of Texas System | T cell receptors for immunotherapy |
| CN110272482B (zh) * | 2018-03-14 | 2022-08-19 | 中国科学院广州生物医药与健康研究院 | 识别prame抗原短肽的t细胞受体 |
| CN110818802B (zh) * | 2018-08-08 | 2022-02-08 | 华夏英泰（北京）生物技术有限公司 | 一种嵌合t细胞受体star及其应用 |
| AR117735A1 (es) | 2018-12-25 | 2021-08-25 | Joint Stock Company Biocad | ANTICUERPOS MONOCLONALES QUE SE UNEN ESPECÍFICAMENTE A LA REGIÓN b DE LA FAMILIA TRBV-9 DEL RECEPTOR DE CÉLULAS T HUMANO, Y LOS MÉTODOS PARA SU USO |
| CA3135850A1 (en) * | 2019-04-05 | 2020-10-08 | Rootpath Genomics, Inc. | Compositions and methods for t-cell receptor gene assembly |
| US20220401484A1 (en) * | 2019-11-18 | 2022-12-22 | BioNTech SE | Prame TCR Receptors And Uses Thereof |
| CN110964122B (zh) * | 2019-12-24 | 2022-04-15 | 南京北恒生物科技有限公司 | T细胞受体融合蛋白及其用途 |
| KR20220160040A (ko) * | 2020-03-27 | 2022-12-05 | 2세븐티 바이오, 인코포레이티드 | T 세포 수용체 |
| CN111690051B (zh) * | 2020-06-28 | 2021-08-17 | 英威福赛生物技术有限公司 | 靶向ny-eso-1(157-165)表位的特异性t细胞受体及抗肿瘤应用 |
| KR102587454B1 (ko) * | 2020-10-07 | 2023-10-11 | 주식회사 다안바이오테라퓨틱스 | T 세포 수용체, t 세포 수용체를 포함하는 면역 세포 및 이를 이용하는 방법 |
| WO2022233956A1 (en) | 2021-05-05 | 2022-11-10 | Immatics Biotechnologies Gmbh | Antigen binding proteins specifically binding prame |
| KR20240005865A (ko) * | 2021-05-07 | 2024-01-12 | 메디진 이뮤노테라피스 게엠바하 | Prame 특이적 t 세포 수용체 및 키메라 공동 자극 수용체의 조합 |
| CN118265721A (zh) * | 2021-10-18 | 2024-06-28 | 得克萨斯州大学系统董事会 | 靶向ndc80抗原的肽和经改造t细胞受体及使用方法 |
| WO2023175069A1 (en) | 2022-03-16 | 2023-09-21 | Medigene Immunotherapies Gmbh | Tcr constant region pairing library for pramevld tcrs |
| CN119677842A (zh) * | 2022-03-17 | 2025-03-21 | 科士华(南京)生物技术有限公司 | 人工合成肿瘤浸润淋巴细胞 |
| EP4609202A2 (en) * | 2022-10-28 | 2025-09-03 | Memorial Sloan-Kettering Cancer Center | T cell receptors targeting ewsr1-wt1 fusion protein and uses thereof |
| WO2024123975A2 (en) * | 2022-12-07 | 2024-06-13 | Board Of Regents, The University Of Texas System | A t cell receptor recognizing an unmutated foxm1 epitope presented on hla-a*02:01 |
| WO2024163292A1 (en) * | 2023-01-30 | 2024-08-08 | Board Of Regents, The University Of Texas System | T-cell receptors targeting her2 and methods of use thereof |
| CN118221811B (zh) * | 2023-08-25 | 2025-05-30 | 立凌生物制药(苏州)有限公司 | 靶向prame多肽的单域抗体及其用途 |
| WO2025247325A1 (en) * | 2024-05-30 | 2025-12-04 | Hanx Biopharmaceuticals, (Wuhan) Ltd. | Antibody-drug conjugates targeting trbv12 and uses thereof |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1118860A1 (en) * | 2000-01-21 | 2001-07-25 | Rijksuniversiteit te Leiden | Methods for selecting and producing T cell peptide epitopes and vaccines incorporating said selected epitopes |
| BRPI0408315A (pt) * | 2003-03-14 | 2006-03-07 | Wyeth Corp | anticorpo isolado, composição farmacêutica, ácido nucleico isolado, vetor de expressão, célula hospedeira, métodos de produzir um anticorpo, de gerar um anticorpo ou fragmento de ligação de antìgeno, de regular uma resposta imune, de tratar ou prevenir um distúrbio associado com célula imune em um paciente, de tratar ou prevenir um distúrbio hiperproliferativo em um paciente, e, kit de diagnóstico |
| EP2006376A1 (en) | 2007-06-21 | 2008-12-24 | Helmholtz Zentrum München Deutsches Forschungszentrum für Gesundheit und Umwelt GmbH | Fusion protein comprising a caspase domain and a nuclear hormone receptor binding domain and methods and uses thereof |
| WO2009026116A2 (en) | 2007-08-16 | 2009-02-26 | Genizon Biosciences, Inc. | Genemap of the human genes associated with longevity |
| AU2012276908A1 (en) | 2011-06-28 | 2014-02-20 | International Institute Of Cancer Immunology, Inc. | Receptor gene for peptide cancer antigen-specific T cell |
-
2017
- 2017-06-16 AU AU2017286310A patent/AU2017286310A1/en not_active Abandoned
- 2017-06-16 KR KR1020187037617A patent/KR102436129B1/ko active Active
- 2017-06-16 WO PCT/EP2017/064729 patent/WO2017216324A1/en not_active Ceased
- 2017-06-16 CN CN201780036677.2A patent/CN109715669B/zh not_active Expired - Fee Related
- 2017-06-16 JP JP2018565885A patent/JP6989138B2/ja not_active Expired - Fee Related
- 2017-06-16 US US16/309,902 patent/US11732020B2/en active Active
- 2017-06-16 ES ES17736576T patent/ES2949342T3/es active Active
- 2017-06-16 EP EP17736576.4A patent/EP3472208B9/en active Active
- 2017-06-16 CA CA3022129A patent/CA3022129A1/en active Pending
-
2023
- 2023-08-21 US US18/236,327 patent/US20240083967A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019527041A5 (OSRAM) | ||
| TWI828625B (zh) | 引導及導航控制蛋白質以及彼之製造及使用方法 | |
| Sommermeyer et al. | Fully human CD19-specific chimeric antigen receptors for T-cell therapy | |
| JP6640726B2 (ja) | キメラ抗原受容体及びその製造方法 | |
| JP7573441B2 (ja) | ガイダンス及びナビゲーションコントロール蛋白質並びにその生産及び使用方法 | |
| Inaguma et al. | Construction and molecular characterization of a T-cell receptor-like antibody and CAR-T cells specific for minor histocompatibility antigen HA-1H | |
| RU2018107802A (ru) | Полностью человеческие антитела к мезотелину и иммунные эффекторные клетки, нацеленные на мезотелин | |
| JP2018524987A5 (OSRAM) | ||
| RU2018105963A (ru) | Антитело против глипикана-3 и его применение | |
| Boettcher et al. | Development of CAR T cell therapy in children—A comprehensive overview | |
| JP2015527070A5 (OSRAM) | ||
| RU2017121826A (ru) | Т-клетки, модифицированные химерным рецептором антигена, нацеленным на cs1 | |
| EA201590216A1 (ru) | Способы оценки пригодности трансдуцированных t-клеток для введения | |
| JP2018522564A5 (OSRAM) | ||
| JP2019525771A5 (OSRAM) | ||
| NZ759969A (en) | Tagged chimeric effector molecules and receptors thereof | |
| JP2017537972A5 (OSRAM) | ||
| RU2017133637A (ru) | Иммуномодулирующие слитые белки и пути их применения | |
| JP2018508219A5 (OSRAM) | ||
| RU2013147157A (ru) | Способ и композиции для клеточной иммунотерапии | |
| RU2017111298A (ru) | Т-КЛЕТКИ С КОСТИМУЛИРУЮЩИМ ХИМЕРНЫМ АНТИГЕННЫМ РЕЦЕПТОРОМ, НАЦЕЛЕННЫЕ НА IL13Rα2 | |
| RU2018113510A (ru) | Химерные рецепторы антигена, нацеленные на psca | |
| Fujiwara | Adoptive immunotherapy for hematological malignancies using T cells gene-modified to express tumor antigen-specific receptors | |
| Hofland et al. | Engaging cytotoxic T and NK cells for immunotherapy in chronic lymphocytic leukemia | |
| Golay et al. | Combined anti-cancer strategies based on anti-checkpoint inhibitor antibodies |